University Hospitals and Athersys, a Cleveland based biotech company, have announced the start of the Macovia study, a clinical trial that will test the effectiveness of cell therapy for COVID-19 patients suffering from Acute Respiratory Distress Syndrome (ARDS) which is the leading cause of death for COVID-19 patients. University Hospitals has already concluded the initial phases of implementing the trial and has started screening and enrolling patients and soon other hospitals across the country will join as the goal is to enroll 400 patients.
anonymousCoronavirus May 06, 2020 at 10:04 am
00
Thought Tags
Get Social and Share